MondayJun 05, 2023 10:02 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Enters Development, Commercialization Agreement for Novel Anti-IL-17 Antibody

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has signed an exclusive worldwide license agreement. The agreement, which is part of its ongoing collaboration with the Max Planck Society and the University Medical Center Gottingen (“UMG”), outlines the development and commercialization of VHH antibodies (NanoAbs) targeting Interleukin-17 (“IL-17”) as treatments for all potential indications; the agreement notes that development will start with a focus on psoriasis and psoriatic arthritis. According to the announcement, BiondVax will lead out on the development and commercialization of…

Continue Reading

MondayJun 05, 2023 9:45 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Servicing Underserved and Overlooked Markets Driving a Cashless Society

Digital money is replacing physical cash, and FEXD is developing mobile transaction platforms and services that are helping implement the coming changes in the fintech market FEXD plans to acquire and merge with companies that include country-based fintech pioneers with global scalability, fintech service providers, companies with large customer bases, and more The company is helping ensure humanity has a path forward from archaic and restrictive cash systems – reducing poverty, improving the lives of the unbanked, providing critical financial options for migrant workers, connecting families and communities, empowering charities and women, and educating underprivileged children With plans to offer…

Continue Reading

MondayJun 05, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Animal Study Showing Its Patented DehydraTECH(TM) Technology Significantly Enhances Oral Delivery of Estradiol; Raises $2 Million in Gross Proceeds from Public Offering

Lexaria recently completed its animal study HOR-A22-1 showing its patented DehydraTECH(TM) technology dramatically enhanced the oral delivery of estradiol, a type of estrogen hormone The use of DehydraTECH resulted in ~900% higher peak concentration of estradiol in the bloodstream compared to the control, as well as a 2,000% increase in the levels of estrone Estrone is a type of estrogen that can be reversibly made from estradiol in certain tissues within the female body The study HOR-A22-1 also revealed that DehydraTECH resulted in 1,500% and 12,500% higher exposure to estradiol and estrone over time, respectively, compared to the control Lexaria…

Continue Reading

FridayJun 02, 2023 11:40 am

QualityStocksNewsBreaks – VCI Global Limited (NASDAQ: VCIG) Subscribes to GlobexUS Shares, Expands into Digital Asset Market

VCI Global (NASDAQ: VCIG), a multidisciplinary consulting group with key advisory practices in the areas of business and technology, is expanding into the digital asset market with its just-announced subscription for 500 new GlobexUS Holdings Corp (“GlobexUS”) shares. According to the company, the shares will be subscribed at $3,000 per share for a total of $1.5 million. The announcement noted that GlobexUS is the holding company of the 50/50 joint venture technology partner of Upstream Exchange, a MERJ Exchange market. Upstream is the world’s first regulated exchange that lists blockchain-based digital securities to be traded on its retail marketplace; the…

Continue Reading

FridayJun 02, 2023 11:15 am

CISO Global Inc. (NASDAQ: CISO) Provides Essential Protection Against Cybersecurity Threats

Smart organizations are encouraged to meet certain standards and regulations to protect data against cybersecurity threats With more than 15 billion user credentials scattered across the dark web, the threat is real CEO notes that compliance is an important driver for security, and organizations should never view it as a mere technical nuisance Complying with security requirements should be about more than just ticking off mandatory checkboxes, says CISO Global (NASDAQ: CISO) CEO David Jemmett (https://ibn.fm/dDN38). CISO Global, formerly Cerberus Cyber Sentinel Corp., works closely with companies to provide essential protection, and Jemmett is a recognized expert in the field…

Continue Reading

FridayJun 02, 2023 10:59 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Interpublic Group of Companies Inc. (NYSE: IPG) Announce Strategic Collaboration

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and Interpublic Group (NYSE: IPG), one of the world’s premier global advertising and marketing services companies, today announced a partnership that will see the companies work together on quantum computing applications that fuel innovation in marketing investments and strategy. D-Wave and IPG will collaborate on the research and development of quantum-hybrid applications designed to address optimization in marketing campaigns. “In today’s highly connected and deeply digital world, consumers are met with brand messages daily. Breaking through to reach the right customer at the right time remains a difficult…

Continue Reading

FridayJun 02, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israel Conference

Biotechnology innovator BiondVax Pharmaceuticals is dedicated to developing nanosized antibody (NanoAb) treatment BiondVax is also leveraging its team experience in preclinical stage to Phase 3 clinical trial product development to generate new revenues by offering cGMP contract development and manufacturing organization (“CDMO”) services The company recently exhibited its CDMO expertise as well as its NanoAb development pipeline at the 21st annual Biomed Israel conference, which drew over 6,000 attendees from a wide variety of international life sciences disciplines BiondVax’s NanoAb drug candidate pipeline has expanded focus on immune system cytokine targets for treating psoriasis and psoriatic arthritis Israel-based biotechnology company…

Continue Reading

FridayJun 02, 2023 9:45 am

Mullen Automotive Inc. (NASDAQ: MULN) Inks Class 3 Truck PO, Purchase Agreement in Continued Upward Momentum

MULN received an order for one thousand class 3 trucks from its dealer partner, Randy Marion Automotive The company is excited about entering the next phase of its commercial launch with the Mullen THREE Mullen inked a $15 million vehicle purchase agreement with the MGT Lease Company for 250 class 3 cab chassis EV trucks On the heels of several purchase agreements and orders, Mullen Automotive (NASDAQ: MULN) is experiencing impressive momentum as it continues to focus on growing in the electric vehicle space. Most recently, the company received a 1,000-unit purchase order (https://ibn.fm/2tLyU) and announced a $15.7 million vehicle purchase…

Continue Reading

FridayJun 02, 2023 9:15 am

Genprex Inc.’s (NASDAQ: GNPX) Inspiring Patient Video on Gene Therapy’s Potential in NSCLC Treatment

Gene Therapy's Transformative Potential Highlighted in Inspiring Patient Video Interview with Genprex’s (NASDAQ: GNPX) REQORSA on Benzinga. Click Here for the full article The interview showcases the real-life experience of a patient participating in a clinical trial utilizing Genprex's innovative gene therapy drug candidate, REQORSA, shedding light on the significant impact it could potentially have in advancing the treatment of non-small cell lung cancer. The featured video highlights the compelling story of Jacqueline Marino, a participant in the Phase 1 segment of Genprex's Phase 1/2 Acclaim-1 clinical trial. Marino, diagnosed with non-small cell lung cancer (“NSCLC”), offers an inspiring account…

Continue Reading

FridayJun 02, 2023 9:00 am

Biogas Boom: EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)’s Leadership Position in Canada’s Global Sustainability Push

In 2019, Quebec became the first Canadian province to mandate the inclusion of renewable natural gas (“RNG”) in natural gas distribution; other provinces have followed suit EverGen Infrastructure as a renewable energy leader in Canada, specializing in RNG with operations in B.C., Alberta, and Ontario EverGen has agreements with provincial governments and businesses to bat for organic feedstock and supply agreements with major Canadian utilities, including FortisBC, to include RNG in their pipelines Renewable energy forms a cornerstone of environmental sustainability, with nations worldwide realizing the immense potential of harnessing naturally occurring energy sources. One such pivotal renewable source is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered